Simplex Trading, LLC Concert Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

$2.98 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$4.34 - $5.84 $2,052 - $2,762	-473 Reduced 7.55%	5,789 $33,000
Q3 2022 Nov 04, 2022	BUY	$4.27 - $7.2 $26,123 - $44,049	6,118 Added 4248.61%	6,262 $41,000
Q2 2022 Aug 03, 2022	SELL	$2.8 - $6.36 $23,307 - $52,940	-8,324 Reduced 98.3%	144 $0
Q1 2022 May 02, 2022	SELL	$2.73 - $3.94 $24,078 - $34,750	-8,820 Reduced 51.02%	8,468 $28,000
Q2 2021 Aug 12, 2021	BUY	$3.77 - $5.24 $23,283 - $32,362	6,176 Added 55.58%	17,288 $72,000
Q1 2021 Apr 26, 2021	BUY	$4.86 - $13.07 $54,004 - $145,233	11,112 New	11,112 $55,000
Q3 2020 Oct 14, 2020	SELL	$8.67 - $10.82 $10,577 - $13,200	-1,220 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$7.8 - $11.52 $5,701 - $8,421	-731 Reduced 37.47%	1,220 $12,000
Q1 2020 Apr 29, 2020	SELL	$5.98 - $13.09 $75,670 - $165,640	-12,654 Reduced 86.64%	1,951 $17,000
Q4 2019 Feb 05, 2020	BUY	$5.71 - $9.22 $45,954 - $74,202	8,048 Added 122.74%	14,605 $134,000
Q3 2019 Oct 15, 2019	BUY	$5.88 - $12.35 $31,452 - $66,060	5,349 Added 442.8%	6,557 $38,000
Q2 2019 Jul 26, 2019	BUY	$9.44 - $13.12 $11,403 - $15,848	1,208 New	1,208 $14,000
Q1 2019 Apr 18, 2019	SELL	$12.07 - $17.54 $253 - $368	-21 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$11.25 - $16.17 $900 - $1,293	-80 Reduced 79.21%	21 $0
Q3 2018 Oct 23, 2018	SELL	$12.82 - $17.88 $48,254 - $67,300	-3,764 Reduced 97.39%	101 $1,000
Q2 2018 Jul 30, 2018	BUY	$16.83 - $21.66 $65,047 - $83,715	3,865 New	3,865 $65,000
Q1 2018 Apr 26, 2018	SELL	$19.24 - $28.03 $346 - $504	-18 Closed	0 $0
Q4 2017 Jan 10, 2018	SELL	$13.96 - $29.05 $209,958 - $436,912	-15,040 Reduced 99.88%	18 $0
Q3 2017 Oct 25, 2017	BUY	$13.91 - $15.31 $209,456 - $230,537	15,058	15,058 $222,000

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account